MPMark P. Purdue

Mark P. Purdue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mark P. Purdue has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:

  • Nathaniel Rothman

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, USA

    92 shared publications
  • Demetrius Albanes

    Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA

    52 shared publications
  • Qing Lan

    Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland USA

    47 shared publications
  • Richard B. Hayes

    Division of Epidemiology, Department of Population Health, New York University School of Medicine, New York, USA

    45 shared publications
  • Jonathan N. Hofmann

    Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA

    38 shared publications
  • Patricia Hartge

    Division of Cancer Epidemiology and Genetics; National Cancer Institute , Rockville, Maryland

    38 shared publications

Latest Publications

  • Environmental Epidemiology in Military Populations: Summary and Conclusions of the First Military Environmental Epidemiology Symposium

    by Jennifer A Rusiecki, Jordan McAdam, Mark P Purdue, Aaron Schneiderman, Celia Byrne, Elizabeth R Heitz, Rudolph P Rull, M Ryan Smith, Shauna L Stahlman, Kimberly Sullivan

    Introduction: On April 22, 2025, researchers from the Department of Defense (DoD) (currently referred to as Department of War [DoW]), Department of Veterans Affairs, National Institutes of Health, and other institutions convened for the inaugural Military Environmental Epidemiology Symposium (MEES) at the Uniformed Services University in Bethesda, Maryland. Materials and Methods: Leading experts explored the state of research, including research resources and infrastructure, and identified critical challenges, future opportunities, and strategies for advancing the field. Results: Presentations highlighted contributions from ongoing large-scale studies, that is, the Millennium Cohort Study and the Million Veterans Program, and case-control studies nested in the DoD Serum Repository (DoDSR) cohort to understanding long-term health impacts of military service and environmental exposures. Valuable sources of data and biospecimens, such as the Defense Medical Surveillance System, Military Health System Data Repository, DoDSR, and Boston Biorepository, Recruitment and Integrated Network for Gulf War Illness (BBRAIN) were described. Exposure assessment methods, ranging from measuring key toxins and multi-omics in DoDSR serum samples to utilizing of military occupational coding, were discussed. Key exposure research areas highlighted were burn pits, per- and polyfluoroalkyl substances, polycyclic aromatic hydrocarbons, jet fuels, Gulf War exposures, and occupational hazards. The MEES focused on identifying critical challenges in the field, such as exposure data limitations, biospecimen and data access/sharing difficulties, data quality concerns, and the complexity of military exposures. Conclusions: Recommendations for future research strategies emphasized leveraging existing data and biospecimen resources, capitalizing on multi-omics technologies, advancing military exposure assessment, fostering cross-institutional collaborations, and applying new analytical tools.

  • Circulating pre-diagnostic metabolites and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a population-based study of 12 cohorts

    by Cody Z Watling, Eleanor L Watts, Erikka Loftfield, Barry I Graubard, Hyokyoung G Hong, Xuehong Zhang, Matthew J Barnett, Julie E Buring, Mollie E Barnard, Yu Chen, et al.

    Background: Underlying metabolic perturbations may offer insight into etiological factors related to liver cancer development. The objective of this study was to explore associations between pre-diagnostic metabolites and risk of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Methods: We conducted a nested case-control study within 12 prospective US cohort studies, including 727 HCC cases and 126 ICC cases with matched controls. Metabolomic profiling was performed on pre-diagnostic blood samples using the Metabolon platform. Multivariable conditional logistic regression estimated adjusted odds ratios and 95% confidence intervals for associations between metabolites (per doubling in levels) and liver cancer risk. Elastic net regression selected metabolites predictive of HCC and ICC, with predictive performance assessed by area under the curve (AUC). Results: Median time from blood collection to diagnosis was 11.6 years. Of 1485 pre-diagnostic metabolites, 600 were associated with HCC risk after false discovery rate correction (366 positively, 234 negatively); no metabolites were significantly associated with ICC. Enriched pathways among HCC cases included methylhistidine metabolism, amino acid metabolism, and bile acid biosynthesis; ICC showed enrichment in valine, leucine, and isoleucine pathways. Elastic net models for HCC selected 38 metabolites with strong predictive performance (AUC = 0.87; 95% CI = 0.83 to 0.91), while 8 metabolites were selected for ICC with modest discrimination (AUC = 0.64; 95% CI = 0.49 to 0.80). Conclusions: Numerous pre-diagnostic metabolites were associated with HCC risk, potentially reflecting underlying liver dysfunction. Enrichment patterns suggest distinct metabolic perturbations between HCC and ICC. Larger studies are needed to characterize metabolic risk factors for ICC and evaluate metabolites as predictors of HCC risk.

  • Open Access

    Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations

    by Hongji Dai, Xinlei Chu, Han Du, Shutong Yang, Yanxin Yao, Xinru Yu, Yanrui Zhao, Pei Dong, Zhangyan Lyu, Wei Wang, et al.

    Renal cell carcinoma (RCC) is the most common type of kidney cancer, but its genetic architecture has not been fully characterized, particularly in Asian populations. Here, we perform a multi-ancestry meta-analysis of 33,712 RCC cases and 845,786 controls, including individuals of East Asian (5,313 cases and 96,912 controls), European (25,890 cases and 743,585 controls), African American (897 cases and 3,109 controls), and Latin American ancestry (1,612 cases and 2,180 controls), which unveils 10 novel RCC-associated loci and a Chinese-specific locus at 12p13.33. Leveraging genome-wide association study (GWAS) data and cross-ancestry expression quantitative trait loci (eQTLs) mapping from 266 kidney tissues, we refine the identification of putative causal variants and genes implicated in RCC. These findings are substantiated through CRISPR-based screenings and multiplexed single-cell perturbations. Additionally, we functionally validate a novel association between rs28684409 and the oncogene RPL4 at the complex genetic locus 15q22.31. This comprehensive genetic investigation underscores the utility of integrating cross-ancestry GWASs, QTLs, and functional screens to elucidate the genetic underpinnings of complex diseases.


  • Open Access

    Serum per- and polyfluoroalkyl substances in relation to circulating thyroxine levels and thyroid cancer risk: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial cohort

    by Eun Mi Jung, Jongeun Rhee, Alexander P. Keil, Cari M. Kitahara, Steven C. Moore, Jani Koponen, Panu Rantakokko, Mark P. Purdue


  • Open Access

    Pre‐diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case–control analysis of 12 prospective cohorts

    by Cody Z. Watling, Peter T. Campbell, Barry I. Graubard, Yanyu Wang, Andrew T. Gewirtz, Xuehong Zhang, Matthew J. Barnett, Julie E. Buring, Yu Chen, A. Heather Eliassen, et al.

    The gut‐liver axis may play an important role in hepatocarcinogenesis. However, limited prospective research has explored associations with liver cancer risk. We conducted a nested case–control study based in 12 prospective cohort studies from across the United States, which included 867 cases of liver cancer and 867 matched controls. We measured bacterial translocation markers, specifically immunoglobulin (Ig) A, IgG, and IgM against lipopolysaccharide and flagellin; soluble CD14 (a co‐receptor for lipopolysaccharide); and lipopolysaccharide‐binding protein. Multivariable conditional logistic regression was used to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI) between bacterial translocation marker concentrations per doubling in concentrations and liver cancer risk. Lipopolysaccharide‐binding protein concentrations were most strongly associated with higher liver cancer risk (OR per doubling in concentrations: 1.48, 95% CI: 1.23–1.79). Concentrations of anti‐flagellin IgA (1.13, 1.01–1.28) and IgG (1.13, 1.01–1.28), anti‐lipopolysaccharide IgG (1.20, 1.01–1.42), and soluble CD14 (1.12, 1.01–1.24) were also associated with liver cancer risk. When analyses were separated into hepatocellular carcinoma (HCC, N = 436 cases) and intrahepatic cholangiocarcinoma (ICC, N = 110 cases), no evidence of heterogeneity was observed except for lipopolysaccharide‐binding protein concentrations, which were positively associated with HCC (1.77, 1.34–2.33) but not ICC (0.67, 0.37–1.22; p ‐heterogeneity = .003). Associations did not differ by time to liver cancer diagnosis or other subgroups. These findings support the role of gut barrier dysfunction in hepatocarcinogenesis, necessitating further research to understand the complex interplay among the mechanisms and risk factors disrupting the gut barrier, microbiota, and liver cancer.


  • Pre-diagnostic circulating bile acid concentrations and liver cancer risk: a nested case-control analysis of 12 cohorts

    by Cody Z Watling, Jessica L Petrick, Barry I Graubard, Xuehong Zhang, Matthew J Barnett, Julie E Buring, Yu Chen, A Heather Eliassen, J Michael Gaziano, Jonathan N Hofmann, et al.

    Background: Bile acids are produced in the liver and are important for lipid digestion. Higher-circulating bile acid levels, however, have been linked to metabolic disorders, inflammation, and gut microbiota dysbiosis, which have been implicated in liver carcinogenesis. To date, few epidemiological studies have explored the association between circulating bile acids and liver cancer risk. Methods: We conducted a nested case-control study among 12 prospective cohort studies located in the United States. Fifteen prediagnostic circulating bile acids were measured from blood samples among 872 individuals who developed liver cancer and 872 matched control participants. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable-adjusted conditional logistic regression analysis of circulating bile acid levels and liver cancer risk. Results: Primary conjugated bile acid concentrations were positively associated with higher risk of liver cancer (OR per doubling in concentrations [log2] and 95% CI of glycocholic acid: 1.32, 1.24 to 1.40; glycochenodeoxycholic acid: 1.33, 1.24 to 1.43; taurocholic acid: 1.28, 1.22 to 1.35; and taurchenodeoxycholic acid: 1.32, 1.24 to 1.39). Secondary conjugated bile acids were also positively associated with liver cancer risk (doubling of concentrations OR ranged from 1.11 to 1.22). Unconjugated bile acid concentrations were generally not associated with liver cancer risk, except lithocholic acid (OR per doubling: 1.27, 1.16 to 1.39). When analyses were separated into the 2 main subtypes of liver cancer, hepatocellular carcinoma (HCC; 438 cases/438 controls) and intrahepatic cholangiocarcinoma (ICC; 111 cases/111 controls), significant heterogeneity was observed for primary conjugated bile acid concentrations (all P < .001) that showed positive significant associations with HCC but not ICC. Conclusions: These results suggest that bile acids may be important markers of HCC risk and contribute to hepatocarcinogenesis; however, further research using serial measurements is needed.


  • Open Access

    A case-control study of early-life residential exposure to tetrachloroethylene and risks of childhood cancer and birth defects

    by Jongeun Rhee, Adrian M Michalski, Margaret Gates Kuliszewski, Jamie Musco, Catherine T Adler, Shuai Xie, Melissa C Friesen, Tabassum Insaf, Mark P. Purdue


  • Open Access

    Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

    by Timothy Nguyen, Alzina Koric, Chun‐Pin Esther Chang, Christine Barul, Loredana Radoi, Diego Serraino, Mark P. Purdue, Karl T. Kelsey, Michael D. McClean, Eva Negri, et al.

    Introduction: The relations between coffee and tea consumption and head and neck cancer (HNC) incidence are unclear. With increasing global HNC burden, this study aims to examine the association between coffee, tea, and HNC.Methods: A pooled analysis of 9548 HNC cases and 15,783 controls from 14 individual‐level case‐control studies was conducted from the International Head and Neck Cancer Epidemiology consortium. Random‐effects logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for HNC and its subsites, adjusting for sociodemographic and lifestyle factors.Results: Compared to non–coffee drinkers, drinking >4 cups of caffeinated coffee daily was inversely associated with HNC (OR, 0.83; 95% CI, 0.69–1.00), oral cavity (OR, 0.70; 95% CI, 0.55–0.89), and oropharyngeal cancers (OR, 0.78; 95% CI, 0.61‐0.99). Drinking 3–4 cups of caffeinated coffee was inversely associated with hypopharyngeal cancer (OR, 0.59; 95% CI, 0.39–0.91). Drinking decaffeinated coffee and drinking between >0 to 0 to ≤1 cup was inversely associated with HNC (OR, 0.91; 95% CI, 0.84–0.98) and hypopharyngeal cancer (OR, 0.73; 95% CI, 0.59–0.91), but drinking >1 cup was associated with laryngeal cancer (OR, 1.38; 95% CI, 1.09–1.74).Conclusion: These findings support reduced HNC risk among coffee and tea drinkers. Future studies are needed to address geographical differences in types of coffee and tea to improve our understanding of the association of coffee and tea and global HNC risk.


  • Open Access

    Serum concentrations of per- and polyfluorinated substances and risk of B-cell non-Hodgkin lymphoma

    by Jongeun Rhee, Jani Koponen, Joshua N. Sampson, Alexander P. Keil, Mary H. Ward, Jonathan N. Hofmann, Wen-Yi Huang, Debra T. Silverman, Panu Rantakokko, Mark P. Purdue


  • Open Access

    Occupational exposure to benzene and risk of non‐ Hodgkin lymphoma in an extended follow‐up of two population‐based prospective cohorts of Chinese men and women

    by Bryan A. Bassig, Xiao‐Ou Shu, Melissa C. Friesen, Roel Vermeulen, Mark P. Purdue, Bu‐Tian Ji, Gong Yang, Jason Y. Y. Wong, Nathan Appel, Wei Hu, et al.

    The carcinogenicity of benzene was reevaluated by the International Agency for Research on Cancer in 2017, with the Working Group reaffirming positive yet inconclusive associations with non‐Hodgkin lymphoma (NHL). To extend our previous observation of a significant exposure‐response for cumulative occupational benzene exposure and NHL risk among Chinese women in a population‐based cohort in Shanghai, we extended follow‐up of this cohort and pooled the data with a similarly designed population‐based cohort of men in Shanghai. Cumulative exposure estimates were derived for 134,449 participants in the pooled analysis by combining ordinal job‐exposure matrix intensity ratings with quantitative benzene measurements from an inspection database of Shanghai factories. Associations between benzene exposure metrics and NHL ( n = 363 cases including multiple myeloma [MM]) were assessed using Cox proportional hazard models. Ever occupational exposure to benzene in the pooled population was associated with NHL risk (HR = 1.5, 95% CI = 1.2–2.0), and exposure‐response relationships were observed for increasing duration ( p trend = .003) and cumulative exposure ( p trend = .003). Associations with ever exposure, duration, and cumulative exposure were similar for NHL with and without MM in the case definition, including lifetime cumulative exposures in the highest quartile (HR = 1.6, 95% CI = 1.1–2.4 with MM included; HR = 1.7, 95% CI = 1.1–2.7 with MM excluded). An elevated risk of the chronic lymphocytic leukemia subtype was suggested in the pooled analyses (HR for ever vs. never exposure = 2.3, 95% CI = 0.9–5.6). These observations provide additional support for a plausible association between occupational benzene exposure and risk of NHL.